Arthneeti

KMC Speciality Hospitals (India) Q1 FY27 Share Price & Earnings Call Analysis

₹149.52+3.30% today
Market cap
₹2,439 Cr
P/E
43.73
ROE
24.93%
PEG
2.15
Price to sales
7.37
Debt to equity
0.40
52W high / low
₹183 / ₹68.9
Sales growth (5Y)
24.40%
EBITDA margin
30.20%
Net profit margin
15.28%
Promoter holding
75.00%
Sales (last year)
₹331 Cr

Incorporated in 1982, KMC Speciality Hospitals (India) is in the healthcare sector running, operating, maintaining multi-specialty hospital in Trichy. The company belongs to the Kauvery Hospitals group. The Company is primarily engaged in the business of rendering medical and healthcare services.

Potential multibaggers · Q2 FY27

Potential multibaggers in Healthcare Services
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Aster DM Quality Care LtdGood growth
    3
See all potential multibaggersWhere does KMC Speciality rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Healthcare Services companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹921 Cr—
240%+Flat₹575 Cr21.9
3Aster DM Quality Care Ltd20–40%Up 2%+₹59,405 Cr164.6
420–40%Up 2%+₹551 Cr18.5
520–40%Up 0–2%₹1,635 Cr16.5
620–40%Flat₹1.21L Cr57.7

Sign up free to see every company in the sector ranking and track KMC Speciality.

Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services ranking

Financials of KMC Speciality

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of KMC Speciality

Quarterly Results

Quarter-by-quarter operating performance

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales +40414142494553566161677582
Expenses +30303131353340444546505457
Operating Profit10111011141213131615162125
OPM %25%27%25%26%29%26%24%22%26%25%25%28%30%
Other Income +1121111011111
Interest0000002322222
Depreciation2222234555555
Profit before tax9109912975109101518
Tax %28%25%26%26%24%25%26%27%25%49%25%26%26%
Net Profit +677797648581114
EPS in Rs0.390.450.430.420.580.430.340.240.460.280.460.660.84

Financials of KMC Speciality

Profit & Loss

Annual income statement trend

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales +32364355718296103136156177232284
Expenses +303135425666757999114129174207
Operating Profit26812141621233742485777
OPM %5%16%19%23%20%20%22%23%28%27%27%25%27%
Other Income +3010021223434
Interest22211111112109
Depreciation443344567891921
Profit before tax-2048101217183236413252
Tax %-81%0%21%33%32%30%30%29%26%26%25%32%
Net Profit +-00357912132427302137
EPS in Rs-0.020.010.200.330.410.530.720.781.461.641.861.312.24
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%0%

Financials of KMC Speciality

Balance Sheet

Capital structure and asset base

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital16161616161616161616161616
Reserves-6-6-38142334477097127148166
Borrowings +161410615109292950828986
Other Liabilities +776881011131318383231
Total Liabilities33312938536070105129182264286300
Fixed Assets +28252324373639747584206248245
CWIP00000002634100
Investments0000000000000
Other Assets +56714162431294863573855
Total Assets33312938536070105129182264286300

Financials of KMC Speciality

Cash Flows

Operating, investing and financing cash movement

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +456101216112629323858
Cash from Investing Activity +-2-1-1-4-19-9-8-43-29-48-56-51
Cash from Financing Activity +-1-5-5-56-5-418-11620-2
Net Cash Flow0-0-01-11-11-0034
Free Cash Flow2556-3137-1516-12-37-6
CFO/OP290%112%91%94%100%113%66%120%102%100%101%112%

Financials of KMC Speciality

Ratios

Working capital efficiency and return ratios

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days1112131213889101099
Inventory Days484232282429593933363138
Days Payable1871691581341431611151179610280153
Cash Conversion Cycle-129-115-112-94-107-125-48-68-53-56-40-105
Working Capital Days-80-70-60-46-37-28-18-15-27-22-73-22
ROCE %2%8%24%35%29%29%33%25%32%27%22%17%
46out of 100

Momentum score · price trend

46 out of 100 — Steady

Over the past year its share price has moved roughly in the middle of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months+110.0%95%
Last 6 months+68.4%94%
Last 3 months+14.1%86%

The price is 21% below its all-time high of ₹183.3 (7 Oct 2026). Stocks more than 20% below their peak have their score halved, so 92 became 46.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For KMC Speciality: 0.4 × 95 + 0.4 × 94 + 0.2 × 86 = 92, halved to 46 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

What KMC Speciality's management said in earlier quarters

Others in Healthcare Services this season

  • Vijaya Diagnostic Centre (Q2 FY27)

    Q2 FY27 Revenue from Operations: INR 2,554 Mn, up 26.7% YoY (Page 10, 9) . Key investor presentation takeaways from Vijaya Diagnostic Centre Ltd's Q2 FY27 inves

  • Shalby (Q2 FY27)

    Consolidated Total Revenue for Q2 FY27: ₹3,182 million vs ₹2,899 million in Q2 FY26, up 9.8% YoY (Pages 5, 6, 8, 9) . Key investor presentation takeaways from S

  • Metropolis Healt (Q2 FY27)

    Q2FY27 revenue from operations: INR 496.8 Cr, up 15.8% YoY (Page 11) . Key investor presentation takeaways from Metropolis Healthcare Ltd's Q2 FY27 investor pre

  • Nephrocare Health Services (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹303.4 Cr, up 23.5% YoY from ₹245.7 Cr in Q2 FY26 (Page 9). Key investor presentation takeaways from Nephrocare Health Services

Compare:vs Apollo Hospitalsvs Max Healthcarevs Manipal Health